Immune to Cancer: The CRI Blog
-
What to Expect in Cancer Immunotherapy in 2021: COVID-19, Biomarkers, and Clinical Trial Design
Dr. Kunle Odunsi shares his thoughts on what lies ahead for the field of cancer immunotherapy.
-
How Bacteria Influence Our Health and Immunity
CRI Lloyd J. Old STAR Dr. Gregory Sonnenberg discusses the science behind the microbiome and what it…
-
Answering More Questions on Genomics and Genetic Testing in Cancer Care
A follow-up for unanswered questions on cancer genomics and genetic testing with Corrie Painter, PhD, and Eliezer Van…
-
How Advances in Genetics and Genomics are Reimagining Cancer Patient Care
Drs. Corrie Painter and Eliezer Van Allen discuss how advances in genetics and genomics are impacting clinical…
-
Immuno-Guided PET Scans May Improve Cancer Patient Treatment Decisions
Dr. Kim Margolin highlights how novel medical imaging technologies may improve how doctors make treatment decisions with…
-
Cancer Immunotherapy in 2020 and Beyond
Dr. Padmanee Sharma discusses progress in hard-to-treat cancers, biomarkers, the microbiome, new treatment approaches, emerging collaboration models,…
-
The Promise of CAR T Cell Therapy in 2019 and Beyond
Dr. Michel Sadelain discusses what’s next in CAR T cell therapy, including the remarkable benefits and the…
-
Speaking With Your Oncologist: The Importance of Building Trust and Open Dialogue
Brendan Connors and his oncologist, Michael Postow, MD, reunited for a special Cancer Immunotherapy Month webinar to…
-
Personalizing Cancer Treatment
Dr. Patrick Hwu discusses the current state of cancer care and how recent advances are enabling doctors…